http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112019027707-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a799d17d5f808bee28dc9a15345a54f |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
filingDate | 2018-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca203b0ecaf7b6dc69d85b4fc6285928 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71014f6c3d108daf8e2bd5de988fab69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf61629a6c7be250c719fef8b04f9735 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27d5b6f08e59ff3dc9b42d10ea44bdfd |
publicationDate | 2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | BR-112019027707-A2 |
titleOfInvention | method for the treatment of dementia, use of a pure 5-ht6 receptor antagonist for the treatment of dementia and pharmaceutical composition |
abstract | the present invention relates to new uses of a 5-ht6 receptor antagonist, specifically 1 - [(2-bromophenyl) sulfonyl] -5-methoxy-3 - [((4-methyl-1-piperazinyl) methyl] -1h- indole or a pharmaceutically acceptable salt thereof, for the treatment of dementia due to menopause, senile dementia, vascular dementia, chemotherapy-induced cognitive impairment and behavioral changes when dementia such as agitation, aggression, depression, anxiety, psychosis, disinhibition, or sleep disorders. the present invention additionally provides for the use of said compounds when manufacturing the intended drug for the treatment of the disorders described herein. |
priorityDate | 2017-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 109.